A Dec. 3, 2020 message from UNC Health CEO Dr. Wesley Burks and Associate Chief Medical Officer Dr. David Weber on what we know about COVID-19 vaccines and the organization’s distribution planning efforts.
The U.S. Food and Drug Administration (FDA) has authorized the Pfizer-BioNTech COVID-19 vaccine for ages 12 to 15 under an emergency use authorization (EUA).
Vaccinating children against COVID-19 is critical to ending this pandemic, and you can help. UNC’s trial site will begin enrolling children 12-17 years of age on May 6.
Our experts strongly recommend that patients receive any one of the COVID-19 vaccines.